Decreased Expression of IL‐35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia
Abstract Recent findings have shown that the level of interleukin‐35 (IL‐35) is abnormal in several autoimmune diseases. Nonetheless, whether IL‐35 participates in the pathogenesis of immune thrombocytopenia (ITP) remains unclear. The current study investigates whether IL‐35 modulates megakaryopoies...
Main Authors: | Xuan Cai, Ruo‐Yun Gui, Jin Wu, Chen‐Cong Wang, Xiao‐Lu Zhu, Hai‐Xia Fu, Xiao‐Hui Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202305798 |
Similar Items
-
Current Insight into the Role of IL-35 and Its Potential Involvement in the Pathogenesis and Therapy of Atopic Dermatitis
by: Weronika Zysk, et al.
Published: (2022-12-01) -
Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious Tolerance
by: Brian M Olson, et al.
Published: (2013-10-01) -
Decreased cyclooxygenase-2 associated with impaired megakaryopoiesis and thrombopoiesis in primary immune thrombocytopenia
by: Xibing Zhuang, et al.
Published: (2023-08-01) -
Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis
by: Qi Wang, et al.
Published: (2017-01-01) -
Interleukin-35 inhibits human umbilical vein endothelial cell injury induced by sera from pre-eclampsia patients by up-regulating S100A8 protein expression
by: Ming Li, et al.
Published: (2020-04-01)